Health-E You Efficacy Trial for Male Adolescents
Launched by JOHNS HOPKINS UNIVERSITY · Jul 24, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Health-E You Efficacy Trial is a study designed to help young men talk about important topics related to sexual and reproductive health. This trial will test a mobile app called Health-E You/Salud ìTu™, which aims to support young males and their healthcare providers in discussing these issues before they visit the doctor. The study will take place in clinical settings and will involve young men aged 12 to 21 who have been sexually active in the past year.
To be eligible for this study, participants must be assigned male at birth, speak English or Spanish, and have access to a phone or the internet for follow-up activities. They should also be willing and able to give their consent to participate. If you or someone you know is interested, please note that the study is not yet recruiting participants, but it aims to create a supportive environment for discussing sexual health among adolescent males. Participants will have the opportunity to use the app and engage in discussions that can help improve their health and well-being.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Assigned male sex at birth
- • Age 12 to 21 years old
- • English and/or Spanish as preferred language to read, listen, and converse
- • Self-reported engagement in vaginal and/or anal sex in the past 12 months
- • Access to phone or internet for follow-up study activities
- Exclusion Criteria:
- • Aged 11 or younger or older than 21
- • Primary language other than English or Spanish
- • Not able to provide informed consent
- • Unable to communicate due to cognitive, mental, language, or other difficulties
- • Not sexually active, engaged in oral sex only, or more than 12 months have passed since last vaginal and/or anal sex.
- • Previous participation in a Health-E You study activity or the app
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Arik V Marcell, MD, MPH
Principal Investigator
Johns Hopkins Dept of Pediatrics / Division of Adolescent/Young Adult Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported